Pineal Parenchymal Tumors With Intermediate Differentiation to Pineoblastoma: A Transitional Neuroectodermal Tumor of the Pineal Gland

被引:0
作者
Jha, Pooja [1 ]
Shukla, Samarth [1 ]
Vagha, Sunita [1 ]
Acharya, Sourya [2 ]
机构
[1] Datta Meghe Inst Higher Educ & Res DMIHER, Jawaharlal Nehru Med Coll, Pathol, Wardha, India
[2] Datta Meghe Inst Higher Educ & Res DMIHER, Jawaharlal Nehru Med Coll, Med, Wardha, India
关键词
third ventricular tumors; who grade; pineoblastoma; pineal tumor of intermediate differentiation; pineal tumors;
D O I
10.7759/cureus.38495
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pineal tumors are quite rare and are fairly aggressive tumors seen in young adults and children. These tumors arise from the pineal region or recess from various types of cells in the gland and structures located in close propinquity to the gland. Pineal gland tumors have a heterogeneous spectrum that includes pineal parenchymal tumors (PPTs) and papillary tumors of the pineal region (PTPR). The PPTs are further subclassified into pineocytomas (Grade 1), PPTs of intermediate differentiation (grade 2 or 3), and pineoblastomas (grade 4) based on the World Health Organization (WHO) grades and histopathological features. We discuss the case of an 11-year-old male child who presented with complaints of headache for 15 days, vomiting for seven days, and diplopia for four days. On magnetic resonance imaging (MRI), a soft tissue density lesion was noticed in the posterior third ventricle region. Based on the location and the MRI findings, the differential diagnosis considered were a pineal lesion, a choroid plexus papilloma, or a meningioma. He underwent a right occipital ventriculoperitoneal shunt followed by total excision of the tumor, and the resected specimen was sent for histopathological examination. After pathologic examination, the diagnosis of pineoblastoma (grade 4) with features of a PPT of intermediate differentiation (grades 2-3) was revealed, and the same was confirmed on immunohistochemistry.
引用
收藏
页数:11
相关论文
共 40 条
  • [31] Combination chemotherapy (cisplatin, vinblastin) and low-dose irradiation in the treatment of pineal parenchymal cell tumors
    Kurisaka, M
    Arisawa, M
    Mori, T
    Sakamoto, T
    Seike, M
    Mori, K
    Okada, T
    Wakiguchi, H
    Kurashige, T
    CHILDS NERVOUS SYSTEM, 1998, 14 (10) : 564 - 569
  • [32] Combination chemotherapy (cisplatin, vinblastin) and low-dose irradiation in the treatment of pineal parenchymal cell tumors
    M. Kurisaka
    Masahiko Arisawa
    Takahisa Mori
    Takashi Sakamoto
    Masato Seike
    Koreaki Mori
    Taisuke Okada
    Hiroshi Wakiguchi
    Takanobu Kurashige
    Child's Nervous System, 1998, 14 : 564 - 569
  • [33] MRI-based assessment of the pineal gland in a large population of children aged 0-5 years and comparison with pineoblastoma: part II, the cystic gland
    Sirin, Selma
    de Jong, Marcus C.
    Galluzzi, Paolo
    Maeder, Philippe
    Brisse, Herve J.
    Castelijns, Jonas A.
    de Graaf, Pim
    Goericke, Sophia L.
    NEURORADIOLOGY, 2016, 58 (07) : 713 - 721
  • [34] PRIMITIVE PINEAL TUMOR WITH RETINOBLASTOMATOUS AND RETINAL CILIARY EPITHELIAL DIFFERENTIATION - AN IMMUNOHISTOCHEMICAL STUDY
    RAISANEN, J
    VOGEL, H
    HOROUPIAN, DS
    JOURNAL OF NEURO-ONCOLOGY, 1990, 9 (02) : 165 - 170
  • [35] MRI-based assessment of the pineal gland in a large population of children aged 0-5 years and comparison with pineoblastoma: part I, the solid gland
    Galluzzi, Paolo
    de Jong, Marcus C.
    Sirin, Selma
    Maeder, Philippe
    Piu, Pietro
    Cerase, Alfonso
    Monti, Lucia
    Brisse, Herve J.
    Castelijns, Jonas A.
    de Graaf, Pim
    Goericke, Sophia L.
    NEURORADIOLOGY, 2016, 58 (07) : 705 - 712
  • [36] Incidence, Prognostic Factors, and Survival Trend in Pineal Gland Tumors: A Population-Based Analysis
    Vuong, Huy Gia
    Ngo, Tam N. M.
    Dunn, Ian F.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations
    Elke Pfaff
    Christian Aichmüller
    Martin Sill
    Damian Stichel
    Matija Snuderl
    Matthias A. Karajannis
    Martin U. Schuhmann
    Jens Schittenhelm
    Martin Hasselblatt
    Christian Thomas
    Andrey Korshunov
    Marina Rhizova
    Andrea Wittmann
    Anna Kaufhold
    Murat Iskar
    Petra Ketteler
    Dietmar Lohmann
    Brent A. Orr
    David W. Ellison
    Katja von Hoff
    Martin Mynarek
    Stefan Rutkowski
    Felix Sahm
    Andreas von Deimling
    Peter Lichter
    Marcel Kool
    Marc Zapatka
    Stefan M. Pfister
    David T. W. Jones
    Acta Neuropathologica, 2020, 139 : 243 - 257
  • [38] Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations
    Pfaff, Elke
    Aichmueller, Christian
    Sill, Martin
    Stichel, Damian
    Snuderl, Matija
    Karajannis, Matthias A.
    Schuhmann, Martin U.
    Schittenhelm, Jens
    Hasselblatt, Martin
    Thomas, Christian
    Korshunov, Andrey
    Rhizova, Marina
    Wittmann, Andrea
    Kaufhold, Anna
    Iskar, Murat
    Ketteler, Petra
    Lohmann, Dietmar
    Orr, Brent A.
    Ellison, David W.
    von Hoff, Katja
    Mynarek, Martin
    Rutkowski, Stefan
    Sahm, Felix
    von Deimling, Andreas
    Lichter, Peter
    Kool, Marcel
    Zapatka, Marc
    Pfister, Stefan M.
    Jones, David T. W.
    ACTA NEUROPATHOLOGICA, 2020, 139 (02) : 243 - 257
  • [39] Review of radiosurgery of pineal parenchymal tumors. Long survival following 125-iodine brachytherapy of pineoblastomas in 2 cases
    Julow, J.
    Viola, A.
    Major, T.
    MINIMALLY INVASIVE NEUROSURGERY, 2006, 49 (05) : 276 - 281
  • [40] CRX/OTX3: A Useful Marker in the Differential Diagnosis of Tumors of the Pineal Region and Indicator of Photoreceptor Differentiation in Medulloblastomas and Atypical Teratoid Rhabdoid Tumors
    Gielen, Gerrit H.
    Gessi, Marco
    Denkhaus, Dorota
    Pietsch, Torsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2013, 21 (03) : 248 - 253